HTA11 U.S. Commercial Payer and Rare Disease Patient Stakeholder Perceptions of Value of Orphan Drugs
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1471
https://www.valueinhealthjournal.com/article/S1098-3015(22)03676-2/fulltext
Title :
HTA11 U.S. Commercial Payer and Rare Disease Patient Stakeholder Perceptions of Value of Orphan Drugs
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03676-2&doi=10.1016/j.jval.2022.09.1471
First page :
Section Title :
Open access? :
No
Section Order :
11015